| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pancreatic Neoplasms | 8 | 2018 | 609 | 0.79 | Why? |
| Carcinoma, Pancreatic Ductal | 5 | 2018 | 112 | 0.69 | Why? |
| Proto-Oncogene Proteins p21(ras) | 4 | 2018 | 100 | 0.55 | Why? |
| Extracorporeal Circulation | 3 | 2021 | 130 | 0.55 | Why? |
| Drainage | 6 | 2019 | 414 | 0.50 | Why? |
| Cholangiopancreatography, Endoscopic Retrograde | 4 | 2019 | 237 | 0.48 | Why? |
| Pancreatitis, Chronic | 3 | 2017 | 37 | 0.47 | Why? |
| Thermodilution | 4 | 2021 | 62 | 0.46 | Why? |
| Cholestasis | 3 | 2018 | 114 | 0.45 | Why? |
| NF-kappa B | 4 | 2017 | 1301 | 0.44 | Why? |
| Pancreatitis, Acute Necrotizing | 2 | 2018 | 47 | 0.36 | Why? |
| Ampulla of Vater | 2 | 2018 | 17 | 0.36 | Why? |
| Proto-Oncogene Proteins | 2 | 2001 | 340 | 0.34 | Why? |
| Colonic Polyps | 2 | 2018 | 117 | 0.33 | Why? |
| Cell Transformation, Neoplastic | 4 | 2018 | 191 | 0.32 | Why? |
| Gastrectomy | 2 | 2017 | 225 | 0.30 | Why? |
| Extravascular Lung Water | 2 | 2021 | 32 | 0.27 | Why? |
| Hepatocytes | 2 | 2018 | 549 | 0.27 | Why? |
| Pancreas | 1 | 2007 | 398 | 0.26 | Why? |
| Endoscopy, Digestive System | 2 | 2018 | 352 | 0.26 | Why? |
| Invasive Pulmonary Aspergillosis | 2 | 2021 | 634 | 0.25 | Why? |
| Mannans | 2 | 2021 | 218 | 0.24 | Why? |
| Liver Cirrhosis | 3 | 2018 | 1810 | 0.23 | Why? |
| I-kappa B Proteins | 1 | 2001 | 21 | 0.23 | Why? |
| Carcinoma, Medullary | 1 | 2001 | 12 | 0.23 | Why? |
| Pancreatic Pseudocyst | 2 | 2018 | 23 | 0.22 | Why? |
| Drosophila Proteins | 1 | 2001 | 67 | 0.22 | Why? |
| T-Lymphocytes, Regulatory | 2 | 2017 | 698 | 0.22 | Why? |
| Cholangitis | 2 | 2019 | 81 | 0.21 | Why? |
| Multiple Organ Failure | 2 | 2021 | 1724 | 0.21 | Why? |
| Injections, Intravenous | 2 | 2018 | 381 | 0.21 | Why? |
| Esophageal Neoplasms | 2 | 2017 | 357 | 0.20 | Why? |
| Hemodynamics | 5 | 2020 | 1562 | 0.20 | Why? |
| Eosinophilic Esophagitis | 1 | 2020 | 35 | 0.20 | Why? |
| Bile Duct Diseases | 1 | 2019 | 12 | 0.20 | Why? |
| Receptor Protein-Tyrosine Kinases | 1 | 2001 | 243 | 0.20 | Why? |
| Stomach Neoplasms | 2 | 2017 | 477 | 0.20 | Why? |
| Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | 1 | 2018 | 3 | 0.20 | Why? |
| Autophagy-Related Protein 5 | 1 | 2018 | 28 | 0.19 | Why? |
| Endoscopes, Gastrointestinal | 1 | 2018 | 11 | 0.19 | Why? |
| Bile | 1 | 2019 | 56 | 0.19 | Why? |
| Indocyanine Green | 1 | 2019 | 66 | 0.19 | Why? |
| Oncolytic Viruses | 1 | 2018 | 20 | 0.19 | Why? |
| Lipase | 1 | 2020 | 153 | 0.19 | Why? |
| Adenomatous Polyps | 1 | 2018 | 21 | 0.19 | Why? |
| MAP Kinase Signaling System | 2 | 2018 | 360 | 0.19 | Why? |
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2018 | 14 | 0.19 | Why? |
| Polyesters | 1 | 2019 | 94 | 0.19 | Why? |
| Oncolytic Virotherapy | 1 | 2018 | 36 | 0.19 | Why? |
| Tail | 1 | 2018 | 5 | 0.19 | Why? |
| Foreign-Body Migration | 1 | 2018 | 25 | 0.19 | Why? |
| DNA-Binding Proteins | 2 | 2001 | 469 | 0.19 | Why? |
| Mucosal-Associated Invariant T Cells | 1 | 2021 | 170 | 0.19 | Why? |
| Femoral Vein | 1 | 2018 | 43 | 0.18 | Why? |
| Rilpivirine | 1 | 2018 | 65 | 0.18 | Why? |
| Transfection | 3 | 2018 | 864 | 0.18 | Why? |
| Proto-Oncogene Proteins c-rel | 1 | 2017 | 2 | 0.18 | Why? |
| Fluoroscopy | 1 | 2018 | 140 | 0.18 | Why? |
| Nuclear Proteins | 2 | 2018 | 321 | 0.18 | Why? |
| Acetylcysteine | 1 | 2001 | 255 | 0.18 | Why? |
| Gastroesophageal Reflux | 1 | 2020 | 124 | 0.18 | Why? |
| TOR Serine-Threonine Kinases | 2 | 2018 | 385 | 0.18 | Why? |
| Plastics | 2 | 2019 | 463 | 0.18 | Why? |
| Jugular Veins | 1 | 2018 | 52 | 0.18 | Why? |
| Adenocarcinoma | 2 | 2017 | 651 | 0.18 | Why? |
| Leptospirosis | 1 | 2019 | 103 | 0.18 | Why? |
| Gene Dosage | 1 | 2018 | 101 | 0.18 | Why? |
| Heart Function Tests | 1 | 2018 | 101 | 0.18 | Why? |
| Receptors, Notch | 1 | 2018 | 59 | 0.18 | Why? |
| Stroke Volume | 2 | 2018 | 2153 | 0.18 | Why? |
| Esophagogastric Junction | 1 | 2017 | 30 | 0.18 | Why? |
| Acinar Cells | 1 | 2017 | 14 | 0.18 | Why? |
| Sphincterotomy, Endoscopic | 1 | 2017 | 27 | 0.17 | Why? |
| Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2016 | 1 | 0.17 | Why? |
| Self Expandable Metallic Stents | 1 | 2018 | 52 | 0.17 | Why? |
| Vascular Remodeling | 1 | 2018 | 99 | 0.17 | Why? |
| Therapeutic Irrigation | 1 | 2018 | 167 | 0.17 | Why? |
| Carbon Dioxide | 2 | 2021 | 917 | 0.17 | Why? |
| Tumor Cells, Cultured | 4 | 2018 | 254 | 0.17 | Why? |
| Cardiac Output | 1 | 2018 | 183 | 0.17 | Why? |
| Endosonography | 1 | 2018 | 150 | 0.17 | Why? |
| Esophagectomy | 1 | 2017 | 76 | 0.17 | Why? |
| Bile Ducts | 1 | 2017 | 84 | 0.16 | Why? |
| Pulmonary Edema | 1 | 2021 | 430 | 0.16 | Why? |
| Endoscopy, Gastrointestinal | 2 | 2018 | 1545 | 0.16 | Why? |
| Transcription, Genetic | 3 | 2017 | 1326 | 0.16 | Why? |
| Pancreatitis | 3 | 2020 | 688 | 0.16 | Why? |
| Cell Lineage | 1 | 2017 | 241 | 0.16 | Why? |
| Fatty Acids | 1 | 2018 | 238 | 0.16 | Why? |
| Stents | 2 | 2018 | 916 | 0.16 | Why? |
| Digestive System Neoplasms | 1 | 2018 | 146 | 0.15 | Why? |
| Gene Silencing | 1 | 2017 | 213 | 0.15 | Why? |
| Precancerous Conditions | 1 | 2016 | 108 | 0.15 | Why? |
| Thyroid Neoplasms | 1 | 2001 | 422 | 0.15 | Why? |
| Transcription Factors | 2 | 2018 | 784 | 0.15 | Why? |
| Mice | 14 | 2018 | 21357 | 0.15 | Why? |
| Carcinoma | 1 | 2018 | 256 | 0.15 | Why? |
| Colonoscopy | 2 | 2018 | 738 | 0.14 | Why? |
| Operative Time | 1 | 2017 | 450 | 0.14 | Why? |
| beta-Glucans | 1 | 2017 | 176 | 0.14 | Why? |
| Transcription Factor RelA | 3 | 2017 | 122 | 0.14 | Why? |
| Alcoholic Beverages | 1 | 2017 | 186 | 0.14 | Why? |
| Cell Movement | 1 | 2018 | 695 | 0.14 | Why? |
| Genetic Vectors | 2 | 2018 | 1600 | 0.14 | Why? |
| Candidiasis | 1 | 2018 | 334 | 0.13 | Why? |
| Respiration, Artificial | 7 | 2021 | 22116 | 0.13 | Why? |
| Candidemia | 1 | 2018 | 353 | 0.13 | Why? |
| Receptors, Cell Surface | 1 | 1998 | 586 | 0.13 | Why? |
| Interstitial Cells of Cajal | 1 | 2013 | 11 | 0.13 | Why? |
| Endocytosis | 1 | 2016 | 451 | 0.13 | Why? |
| Lymphocyte Activation | 2 | 2021 | 2742 | 0.13 | Why? |
| Liver | 2 | 2018 | 4007 | 0.13 | Why? |
| Synaptic Transmission | 1 | 2013 | 46 | 0.13 | Why? |
| Fluid Therapy | 1 | 2018 | 628 | 0.13 | Why? |
| Enteric Nervous System | 1 | 2013 | 28 | 0.13 | Why? |
| Genetic Therapy | 1 | 2018 | 409 | 0.13 | Why? |
| Drug-Eluting Stents | 1 | 2019 | 562 | 0.12 | Why? |
| Image Processing, Computer-Assisted | 2 | 2018 | 1383 | 0.12 | Why? |
| Insulin Resistance | 1 | 2018 | 669 | 0.12 | Why? |
| Bile Duct Neoplasms | 1 | 2015 | 172 | 0.12 | Why? |
| Incidental Findings | 1 | 2017 | 487 | 0.12 | Why? |
| Liver Function Tests | 1 | 2019 | 1325 | 0.12 | Why? |
| Pneumonia, Pneumocystis | 1 | 2017 | 322 | 0.12 | Why? |
| Troponin T | 1 | 2018 | 771 | 0.12 | Why? |
| Enterocolitis | 1 | 2013 | 62 | 0.12 | Why? |
| Renal Dialysis | 2 | 2021 | 4358 | 0.12 | Why? |
| DNA | 1 | 1998 | 778 | 0.12 | Why? |
| Antimicrobial Stewardship | 1 | 2020 | 931 | 0.12 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 1 | 2020 | 800 | 0.12 | Why? |
| Endoscopy | 3 | 2018 | 1564 | 0.11 | Why? |
| Signal Transduction | 6 | 2018 | 7207 | 0.11 | Why? |
| Immunocompetence | 1 | 2013 | 280 | 0.11 | Why? |
| Male | 42 | 2021 | 367725 | 0.11 | Why? |
| Autophagy | 1 | 2018 | 960 | 0.11 | Why? |
| Monitoring, Physiologic | 2 | 2021 | 1956 | 0.11 | Why? |
| Membrane Proteins | 2 | 2018 | 1733 | 0.11 | Why? |
| Galactose | 2 | 2021 | 201 | 0.10 | Why? |
| Aged | 27 | 2021 | 215776 | 0.10 | Why? |
| Middle Aged | 31 | 2021 | 270681 | 0.10 | Why? |
| Gastroscopes | 1 | 2008 | 8 | 0.10 | Why? |
| Female | 37 | 2021 | 380317 | 0.09 | Why? |
| Acute Kidney Injury | 2 | 2020 | 5762 | 0.09 | Why? |
| Prospective Studies | 12 | 2021 | 43301 | 0.09 | Why? |
| Consumer Health Information | 1 | 2017 | 750 | 0.09 | Why? |
| NF-kappa B p52 Subunit | 2 | 2018 | 24 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2018 | 1222 | 0.09 | Why? |
| Mass Media | 1 | 2017 | 837 | 0.09 | Why? |
| HMGA1a Protein | 1 | 2007 | 5 | 0.09 | Why? |
| Mice, Knockout | 3 | 2018 | 1815 | 0.09 | Why? |
| Cell Survival | 3 | 2018 | 1581 | 0.09 | Why? |
| Receptor, Insulin | 1 | 2007 | 18 | 0.09 | Why? |
| Cyclin D1 | 1 | 2007 | 22 | 0.09 | Why? |
| Arterial Pressure | 2 | 2020 | 208 | 0.09 | Why? |
| Anti-Bacterial Agents | 2 | 2020 | 10083 | 0.09 | Why? |
| Colorectal Neoplasms | 2 | 2018 | 1884 | 0.09 | Why? |
| Disease Progression | 6 | 2021 | 13580 | 0.09 | Why? |
| Extracellular Signal-Regulated MAP Kinases | 2 | 2018 | 92 | 0.09 | Why? |
| Gastritis | 1 | 2007 | 66 | 0.08 | Why? |
| Gastric Mucosa | 1 | 2008 | 141 | 0.08 | Why? |
| Gastroscopy | 1 | 2008 | 112 | 0.08 | Why? |
| Inflammation Mediators | 1 | 2019 | 2654 | 0.08 | Why? |
| Esophagus | 2 | 2020 | 139 | 0.08 | Why? |
| Patient Education as Topic | 1 | 2017 | 1476 | 0.08 | Why? |
| Humans | 52 | 2021 | 930598 | 0.08 | Why? |
| Tumor Burden | 2 | 2018 | 369 | 0.08 | Why? |
| Animals | 16 | 2018 | 78931 | 0.08 | Why? |
| Germany | 5 | 2021 | 9196 | 0.08 | Why? |
| Bacterial Infections | 1 | 2020 | 2229 | 0.08 | Why? |
| Intensive Care Units | 8 | 2021 | 29594 | 0.08 | Why? |
| Software | 1 | 2018 | 2501 | 0.08 | Why? |
| Dissection | 1 | 2008 | 164 | 0.08 | Why? |
| Antigen-Presenting Cells | 1 | 2007 | 206 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2018 | 1666 | 0.08 | Why? |
| Endothelium, Vascular | 1 | 2018 | 1751 | 0.08 | Why? |
| Melanoma | 1 | 2017 | 1229 | 0.08 | Why? |
| Cytomegalovirus Infections | 1 | 2013 | 667 | 0.08 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.08 | Why? |
| Gastroenterology | 1 | 2017 | 1352 | 0.08 | Why? |
| Carcinogenesis | 2 | 2018 | 236 | 0.08 | Why? |
| Anti-HIV Agents | 1 | 2018 | 2209 | 0.07 | Why? |
| Myocardium | 1 | 2018 | 2323 | 0.07 | Why? |
| Doxycycline | 2 | 2019 | 307 | 0.07 | Why? |
| Aged, 80 and over | 12 | 2021 | 88759 | 0.07 | Why? |
| Vitamin D Deficiency | 1 | 2018 | 1782 | 0.07 | Why? |
| Mice, Transgenic | 3 | 2018 | 2739 | 0.07 | Why? |
| Cross-Over Studies | 2 | 2018 | 867 | 0.07 | Why? |
| Helicobacter Infections | 1 | 2007 | 216 | 0.07 | Why? |
| Toll-Like Receptors | 1 | 2007 | 365 | 0.07 | Why? |
| Patient Satisfaction | 1 | 2017 | 2517 | 0.07 | Why? |
| Blood Glucose | 1 | 2018 | 3642 | 0.07 | Why? |
| Evolution, Molecular | 1 | 2018 | 3691 | 0.07 | Why? |
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 502 | 0.07 | Why? |
| Helicobacter pylori | 1 | 2007 | 262 | 0.07 | Why? |
| Enterobacteriaceae Infections | 2 | 2020 | 529 | 0.07 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.07 | Why? |
| Promoter Regions, Genetic | 2 | 2017 | 823 | 0.06 | Why? |
| Liver Diseases | 1 | 2019 | 2698 | 0.06 | Why? |
| Mutation | 3 | 2018 | 12376 | 0.06 | Why? |
| Vitamin D | 1 | 2018 | 2904 | 0.06 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.06 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 1573 | 0.06 | Why? |
| Ultrasonography | 1 | 2018 | 4409 | 0.06 | Why? |
| Proto-Oncogene Proteins c-ret | 1 | 2001 | 15 | 0.06 | Why? |
| Cell Line, Tumor | 3 | 2018 | 3608 | 0.06 | Why? |
| Video Recording | 1 | 2008 | 786 | 0.06 | Why? |
| Adult | 18 | 2021 | 244371 | 0.06 | Why? |
| Machine Learning | 1 | 2018 | 4395 | 0.06 | Why? |
| ROC Curve | 3 | 2019 | 6024 | 0.06 | Why? |
| Practice Patterns, Physicians' | 1 | 2020 | 4927 | 0.06 | Why? |
| ras Proteins | 1 | 2001 | 37 | 0.06 | Why? |
| Gastrointestinal Diseases | 1 | 2017 | 2580 | 0.06 | Why? |
| NF-KappaB Inhibitor alpha | 1 | 2001 | 63 | 0.06 | Why? |
| DNA, Neoplasm | 1 | 2001 | 56 | 0.06 | Why? |
| 3T3 Cells | 1 | 2001 | 152 | 0.06 | Why? |
| Retrospective Studies | 11 | 2021 | 105322 | 0.06 | Why? |
| Dilatation | 2 | 2017 | 181 | 0.06 | Why? |
| Bronchoalveolar Lavage Fluid | 2 | 2021 | 2309 | 0.06 | Why? |
| Sulbactam | 1 | 2020 | 37 | 0.06 | Why? |
| Young Adult | 10 | 2021 | 93724 | 0.06 | Why? |
| I-kappa B Kinase | 1 | 2001 | 98 | 0.05 | Why? |
| Emergency Medical Services | 1 | 2018 | 3557 | 0.05 | Why? |
| Mitogen-Activated Protein Kinases | 1 | 2001 | 126 | 0.05 | Why? |
| Cell Differentiation | 2 | 2017 | 1338 | 0.05 | Why? |
| Ampicillin | 1 | 2020 | 73 | 0.05 | Why? |
| Patient Admission | 1 | 2018 | 5250 | 0.05 | Why? |
| Granzymes | 1 | 2021 | 197 | 0.05 | Why? |
| Area Under Curve | 2 | 2018 | 2564 | 0.05 | Why? |
| Gene Expression Regulation | 3 | 2017 | 4020 | 0.05 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.05 | Why? |
| Equipment Design | 3 | 2018 | 3095 | 0.05 | Why? |
| Biopsy | 2 | 2020 | 2811 | 0.05 | Why? |
| Ambulatory Care | 1 | 2017 | 4947 | 0.05 | Why? |
| Dimerization | 1 | 2001 | 475 | 0.05 | Why? |
| Genes, ras | 1 | 2018 | 8 | 0.05 | Why? |
| Linezolid | 1 | 2020 | 160 | 0.05 | Why? |
| Capillary Permeability | 1 | 2021 | 277 | 0.05 | Why? |
| Glucose Clamp Technique | 1 | 2018 | 39 | 0.05 | Why? |
| Hyperbilirubinemia | 1 | 2019 | 81 | 0.05 | Why? |
| Narrow Band Imaging | 1 | 2018 | 24 | 0.05 | Why? |
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 1998 | 4 | 0.05 | Why? |
| Critical Illness | 5 | 2021 | 17281 | 0.05 | Why? |
| Drug Liberation | 1 | 2019 | 141 | 0.05 | Why? |
| Mice, Inbred NOD | 1 | 2018 | 134 | 0.05 | Why? |
| Catecholamines | 1 | 2019 | 66 | 0.05 | Why? |
| Ribosomal Protein S6 Kinases | 1 | 2018 | 2 | 0.05 | Why? |
| Cross Infection | 1 | 2021 | 8675 | 0.05 | Why? |
| Internet | 1 | 2017 | 6204 | 0.05 | Why? |
| Enterococcus | 1 | 2019 | 73 | 0.05 | Why? |
| Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 35 | 0.05 | Why? |
| Genes, myc | 1 | 2018 | 15 | 0.05 | Why? |
| Paracentesis | 1 | 2018 | 25 | 0.05 | Why? |
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2018 | 15 | 0.05 | Why? |
| Receptor, Notch1 | 1 | 1998 | 21 | 0.05 | Why? |
| Cell Nucleus | 1 | 2001 | 399 | 0.05 | Why? |
| Mice, SCID | 1 | 2018 | 225 | 0.05 | Why? |
| Genes, p53 | 1 | 2018 | 20 | 0.05 | Why? |
| Benzoxazoles | 1 | 2018 | 47 | 0.05 | Why? |
| Phosphatidylinositol 3-Kinase | 1 | 2018 | 28 | 0.05 | Why? |
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 45 | 0.05 | Why? |
| Angiopoietins | 1 | 2018 | 45 | 0.05 | Why? |
| Coloring Agents | 1 | 2019 | 116 | 0.05 | Why? |
| Camptothecin | 1 | 2018 | 39 | 0.05 | Why? |
| CD36 Antigens | 1 | 2018 | 44 | 0.05 | Why? |
| Predictive Value of Tests | 3 | 2018 | 9537 | 0.05 | Why? |
| Reproducibility of Results | 3 | 2021 | 11304 | 0.05 | Why? |
| HLA-DR Antigens | 1 | 2021 | 563 | 0.05 | Why? |
| Gastroenterostomy | 1 | 2017 | 5 | 0.04 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2017 | 5002 | 0.04 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2018 | 274 | 0.04 | Why? |
| Newcastle disease virus | 1 | 2018 | 108 | 0.04 | Why? |
| RNA, Small Interfering | 2 | 2017 | 817 | 0.04 | Why? |
| Fatty Acid-Binding Proteins | 1 | 2018 | 93 | 0.04 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.04 | Why? |
| Transillumination | 1 | 2017 | 9 | 0.04 | Why? |
| Chemoradiotherapy, Adjuvant | 1 | 2017 | 69 | 0.04 | Why? |
| Cathepsins | 1 | 2018 | 204 | 0.04 | Why? |
| Jurkat Cells | 1 | 1998 | 273 | 0.04 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.04 | Why? |
| Emtricitabine | 1 | 2018 | 202 | 0.04 | Why? |
| Heterozygote | 1 | 2018 | 249 | 0.04 | Why? |
| Homozygote | 1 | 2018 | 230 | 0.04 | Why? |
| Pamphlets | 1 | 2017 | 27 | 0.04 | Why? |
| Osmotic Pressure | 1 | 2016 | 15 | 0.04 | Why? |
| Estrogen Antagonists | 1 | 2017 | 36 | 0.04 | Why? |
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2018 | 78 | 0.04 | Why? |
| Nucleotide Motifs | 1 | 2017 | 58 | 0.04 | Why? |
| Metaplasia | 1 | 2016 | 43 | 0.04 | Why? |
| Budesonide | 1 | 2020 | 192 | 0.04 | Why? |
| Vancomycin | 1 | 2020 | 328 | 0.04 | Why? |
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 1014 | 0.04 | Why? |
| Homologous Recombination | 1 | 2017 | 32 | 0.04 | Why? |
| Calcium-Binding Proteins | 1 | 2018 | 121 | 0.04 | Why? |
| Pyrimidines | 2 | 2018 | 1557 | 0.04 | Why? |
| Bortezomib | 1 | 2018 | 125 | 0.04 | Why? |
| Radiography, Abdominal | 1 | 2017 | 88 | 0.04 | Why? |
| Streptococcal Infections | 1 | 2020 | 255 | 0.04 | Why? |
| Ceftriaxone | 1 | 2019 | 365 | 0.04 | Why? |
| Aspergillosis | 1 | 2020 | 264 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.04 | Why? |
| Hydrodynamics | 1 | 2018 | 177 | 0.04 | Why? |
| Escherichia coli Infections | 1 | 2020 | 348 | 0.04 | Why? |
| Gene Order | 1 | 2017 | 144 | 0.04 | Why? |
| DNA Transposable Elements | 1 | 2017 | 91 | 0.04 | Why? |
| Neovascularization, Physiologic | 1 | 2018 | 160 | 0.04 | Why? |
| Fibroblasts | 1 | 2001 | 839 | 0.04 | Why? |
| Treatment Outcome | 6 | 2021 | 51732 | 0.04 | Why? |
| Tamoxifen | 1 | 2017 | 83 | 0.04 | Why? |
| Kidney Function Tests | 1 | 2019 | 520 | 0.04 | Why? |
| Vasoconstrictor Agents | 1 | 2020 | 714 | 0.04 | Why? |
| Phenotype | 2 | 2018 | 4037 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Proteoglycans | 1 | 2017 | 130 | 0.04 | Why? |
| Transforming Growth Factor beta1 | 1 | 2018 | 204 | 0.04 | Why? |
| Anastomosis, Surgical | 1 | 2017 | 169 | 0.04 | Why? |
| Prosthesis Failure | 1 | 2018 | 195 | 0.04 | Why? |
| Iatrogenic Disease | 1 | 2019 | 304 | 0.04 | Why? |
| APACHE | 1 | 2019 | 682 | 0.04 | Why? |
| Vesicular stomatitis Indiana virus | 1 | 2018 | 354 | 0.04 | Why? |
| Cohort Studies | 4 | 2020 | 36005 | 0.04 | Why? |
| Automation | 1 | 2018 | 429 | 0.04 | Why? |
| Superinfection | 1 | 2021 | 459 | 0.04 | Why? |
| Pressure | 1 | 2018 | 289 | 0.04 | Why? |
| Transgenes | 1 | 2017 | 227 | 0.04 | Why? |
| Models, Anatomic | 1 | 2017 | 191 | 0.04 | Why? |
| Interleukin-17 | 1 | 2021 | 602 | 0.04 | Why? |
| Gene Knockout Techniques | 1 | 2017 | 347 | 0.04 | Why? |
| Adenoma | 1 | 2018 | 215 | 0.04 | Why? |
| Cell Cycle Proteins | 1 | 2018 | 297 | 0.04 | Why? |
| Adenine | 1 | 2018 | 463 | 0.04 | Why? |
| Health Information Systems | 1 | 2017 | 130 | 0.04 | Why? |
| Lung | 2 | 2021 | 31049 | 0.04 | Why? |
| Gene Deletion | 1 | 2017 | 430 | 0.04 | Why? |
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 334 | 0.04 | Why? |
| Klebsiella Infections | 1 | 2020 | 466 | 0.04 | Why? |
| Time Factors | 4 | 2021 | 31397 | 0.04 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 372 | 0.04 | Why? |
| Genes, Reporter | 1 | 2017 | 472 | 0.04 | Why? |
| Chemoradiotherapy | 1 | 2017 | 362 | 0.04 | Why? |
| Enterobacteriaceae | 1 | 2019 | 395 | 0.04 | Why? |
| Tidal Volume | 1 | 2018 | 565 | 0.04 | Why? |
| Prosthesis Design | 1 | 2018 | 594 | 0.04 | Why? |
| Liver Failure | 1 | 2018 | 266 | 0.04 | Why? |
| Tenofovir | 1 | 2018 | 449 | 0.04 | Why? |
| Analysis of Variance | 1 | 2018 | 950 | 0.04 | Why? |
| Hospital Costs | 1 | 2018 | 274 | 0.04 | Why? |
| Constriction, Pathologic | 1 | 2015 | 212 | 0.04 | Why? |
| ErbB Receptors | 1 | 2016 | 320 | 0.03 | Why? |
| Neoplasm Metastasis | 1 | 2018 | 682 | 0.03 | Why? |
| Abdomen | 1 | 2018 | 424 | 0.03 | Why? |
| Transcriptome | 2 | 2018 | 3466 | 0.03 | Why? |
| Neoadjuvant Therapy | 1 | 2017 | 554 | 0.03 | Why? |
| Feasibility Studies | 2 | 2018 | 3467 | 0.03 | Why? |
| Polymerase Chain Reaction | 2 | 2021 | 6740 | 0.03 | Why? |
| Risk Factors | 5 | 2018 | 71621 | 0.03 | Why? |
| Cyclic GMP-Dependent Protein Kinase Type I | 1 | 2013 | 2 | 0.03 | Why? |
| Candida | 1 | 2018 | 425 | 0.03 | Why? |
| Receptors, Platelet-Derived Growth Factor | 1 | 2012 | 8 | 0.03 | Why? |
| Homeostasis | 1 | 2017 | 582 | 0.03 | Why? |
| Microscopy | 1 | 2017 | 414 | 0.03 | Why? |
| Respiratory Mechanics | 1 | 2018 | 585 | 0.03 | Why? |
| Maximum Tolerated Dose | 1 | 2012 | 65 | 0.03 | Why? |
| Glucose | 1 | 2018 | 573 | 0.03 | Why? |
| Catheterization, Central Venous | 1 | 2018 | 458 | 0.03 | Why? |
| Proto-Oncogene Proteins c-kit | 1 | 2012 | 59 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2021 | 1387 | 0.03 | Why? |
| Capecitabine | 1 | 2012 | 51 | 0.03 | Why? |
| Single-Blind Method | 1 | 2017 | 1283 | 0.03 | Why? |
| Alanine Transaminase | 1 | 2019 | 1329 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.03 | Why? |
| Immunophenotyping | 1 | 2017 | 1290 | 0.03 | Why? |
| Immune Tolerance | 1 | 2017 | 608 | 0.03 | Why? |
| Algorithms | 2 | 2021 | 7346 | 0.03 | Why? |
| Disease Models, Animal | 3 | 2017 | 10998 | 0.03 | Why? |
| Body Weight | 1 | 2018 | 1074 | 0.03 | Why? |
| Mice, Inbred C57BL | 2 | 2017 | 5542 | 0.03 | Why? |
| Deoxycytidine | 1 | 2012 | 116 | 0.03 | Why? |
| Interleukin-6 | 2 | 2020 | 7522 | 0.03 | Why? |
| Fluorouracil | 1 | 2012 | 169 | 0.03 | Why? |
| Contrast Media | 1 | 2018 | 1011 | 0.03 | Why? |
| Diagnosis, Differential | 2 | 2020 | 7220 | 0.03 | Why? |
| Creatinine | 1 | 2018 | 1443 | 0.03 | Why? |
| Clinical Competence | 2 | 2017 | 3263 | 0.03 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.03 | Why? |
| Alleles | 1 | 2018 | 1557 | 0.03 | Why? |
| Tertiary Care Centers | 2 | 2021 | 8248 | 0.03 | Why? |
| Ferritins | 1 | 2020 | 2055 | 0.03 | Why? |
| Gene Expression Profiling | 2 | 2017 | 3788 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2019 | 1755 | 0.03 | Why? |
| Cisplatin | 1 | 2012 | 209 | 0.03 | Why? |
| Treatment Failure | 1 | 2017 | 2106 | 0.03 | Why? |
| Myocytes, Cardiac | 1 | 2018 | 804 | 0.03 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.03 | Why? |
| Staphylococcal Infections | 1 | 2020 | 1099 | 0.03 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.03 | Why? |
| Biomarkers | 3 | 2020 | 23361 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| Apoptosis | 1 | 2001 | 2335 | 0.03 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 1115 | 0.03 | Why? |
| Killer Cells, Natural | 1 | 2021 | 2093 | 0.03 | Why? |
| Sex Factors | 2 | 2018 | 11014 | 0.03 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2021 | 2483 | 0.03 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2017 | 1999 | 0.03 | Why? |
| Microbial Sensitivity Tests | 1 | 2019 | 2886 | 0.03 | Why? |
| Imatinib Mesylate | 1 | 2012 | 327 | 0.03 | Why? |
| Autoimmunity | 1 | 2017 | 841 | 0.03 | Why? |
| Antifungal Agents | 1 | 2020 | 1828 | 0.02 | Why? |
| Benzamides | 1 | 2012 | 421 | 0.02 | Why? |
| Informed Consent | 1 | 2017 | 890 | 0.02 | Why? |
| Alcoholism | 1 | 2017 | 691 | 0.02 | Why? |
| Piperazines | 1 | 2012 | 445 | 0.02 | Why? |
| Positive-Pressure Respiration | 1 | 2018 | 1160 | 0.02 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.02 | Why? |
| Renal Replacement Therapy | 1 | 2018 | 1530 | 0.02 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2021 | 2585 | 0.02 | Why? |
| Patient Selection | 2 | 2018 | 4560 | 0.02 | Why? |
| Pilot Projects | 1 | 2020 | 5182 | 0.02 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2017 | 3395 | 0.02 | Why? |
| Cell Growth Processes | 1 | 2007 | 12 | 0.02 | Why? |
| Protein Kinase Inhibitors | 1 | 2018 | 1585 | 0.02 | Why? |
| Mice, Mutant Strains | 1 | 2007 | 42 | 0.02 | Why? |
| Macrophages, Peritoneal | 1 | 2007 | 38 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2021 | 243684 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.02 | Why? |
| Lymphocytes | 1 | 2020 | 3056 | 0.02 | Why? |
| Cytomegalovirus | 1 | 2013 | 600 | 0.02 | Why? |
| Phosphoproteins | 1 | 2018 | 4346 | 0.02 | Why? |
| Equipment Safety | 1 | 2008 | 167 | 0.02 | Why? |
| Reconstructive Surgical Procedures | 1 | 2017 | 860 | 0.02 | Why? |
| Critical Care | 2 | 2021 | 14081 | 0.02 | Why? |
| Myeloid Differentiation Factor 88 | 1 | 2007 | 109 | 0.02 | Why? |
| Physician-Patient Relations | 1 | 2017 | 1266 | 0.02 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.02 | Why? |
| Serologic Tests | 1 | 2021 | 4359 | 0.02 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.02 | Why? |
| Transcriptional Activation | 1 | 2007 | 196 | 0.02 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.02 | Why? |
| Hospitals, University | 1 | 2018 | 4173 | 0.02 | Why? |
| Acute Disease | 1 | 2019 | 6029 | 0.02 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| Binding Sites | 1 | 2017 | 6201 | 0.02 | Why? |
| Quality Improvement | 1 | 2017 | 2435 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.02 | Why? |
| RNA Interference | 1 | 2007 | 534 | 0.02 | Why? |
| Neutrophils | 1 | 2020 | 5476 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.02 | Why? |
| Pain Measurement | 1 | 2007 | 533 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| Th2 Cells | 1 | 2007 | 680 | 0.02 | Why? |
| Pain, Postoperative | 1 | 2007 | 289 | 0.02 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
| Palliative Care | 1 | 2018 | 2665 | 0.02 | Why? |
| Protein Biosynthesis | 1 | 2007 | 653 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.02 | Why? |
| Minimally Invasive Surgical Procedures | 1 | 2008 | 663 | 0.02 | Why? |
| Tomography, X-Ray Computed | 2 | 2021 | 25144 | 0.01 | Why? |
| Sensitivity and Specificity | 2 | 2017 | 22971 | 0.01 | Why? |
| Research Design | 1 | 2019 | 5830 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.01 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Cells, Cultured | 1 | 2013 | 5835 | 0.01 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.01 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.01 | Why? |
| Th1 Cells | 1 | 2007 | 1228 | 0.01 | Why? |
| Protein Binding | 1 | 2017 | 11430 | 0.01 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.01 | Why? |
| Models, Theoretical | 1 | 2018 | 6659 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Dendritic Cells | 1 | 2007 | 1330 | 0.01 | Why? |
| Registries | 1 | 2017 | 12327 | 0.01 | Why? |
| Virus Replication | 1 | 2018 | 14331 | 0.01 | Why? |
| Recurrence | 1 | 2007 | 3675 | 0.01 | Why? |
| Respiratory Insufficiency | 1 | 2018 | 7301 | 0.01 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| B-Lymphocytes | 1 | 2007 | 4418 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.01 | Why? |